Design and development of thyroxine/heparin releasing affordable cotton dressings to treat chronic wounds
- PMID: 35246945
- DOI: 10.1002/term.3295
Design and development of thyroxine/heparin releasing affordable cotton dressings to treat chronic wounds
Retraction in
-
RETRACTION: Design and development of thyroxine/heparin releasing affordable cotton dressings to treat chronic wounds.J Tissue Eng Regen Med. 2025 Aug 6;2025:9795348. doi: 10.1155/term/9795348. eCollection 2025. J Tissue Eng Regen Med. 2025. PMID: 40808747 Free PMC article.
Abstract
This research on a thyroxine/heparin-based cotton wound dressing tests angiogenic and wound healing ability of thyroxine/heparin in a chick chorionic allantoic membrane bioassay and in skin wounds in healthy rats. Commercially available cotton dressings were simply loaded with thyroxine/heparin solutions and coated with wax. Prior to undertaking the animal study, we assessed in vitro release of thyroxine/heparin from coated and uncoated cotton dressings. Both showed more than 85% release of drug over 14 days, though the lesser release was observed in wax-coated thyroxine/heparin dressing as compared to uncoated thyroxine/heparin dressing. Testing of angiogenesis through CAM assay proved good angiogenic potential of heparin and thyroxin, but the thyroxine found more angiogenic than heparin. In animal study, full-thickness skin wounds of 20 mm diameter showed good healing in both heparin and thyroxine-treated groups. But the most striking result was seen in the thyroxine-treated group where thyroxine showed significant difference with heparin-treated group and completely healed the wounds in 23 days. Thus, the study suggest that thyroxine possesses greater angiogenic and wound healing potential than heparin, and the use of thyroxine/heparin-loaded wax-coated cotton dressing could be a cost-effective option for the management of chronic wounds.
Keywords: CAM assay; angiogenesis; cotton dressing; tissue engineering; wound healing.
© 2022 John Wiley & Sons Ltd.
References
REFERENCES
-
- Abdelrahman, T., & Newton, H. (2011). Wound dressings: Principles and practice. Surgery, 29(10), 491-495.
-
- Ahmed, A., Getti, G., & Boateng, J. (2021). Medicated multi-targeted alginate-based dressings for potential treatment of mixed bacterial-fungal infections in diabetic foot ulcers. International Journal of Pharmaceutics, 606, 120903.
-
- Ahtzaz, S., Waris, T. S., Shahzadi, L., Chaudhary, A. A., & Rehman, U. I. (2019). Boron for tissue regeneration - It’s loading into chitosan/collagen hydrogels and testing on chorioallantoic membrane to study the effect on angiogenesis. International Journal of Polymeric Materials and Polymeric Biomaterials, 69(8), 525-534.
-
- Albini, A., Benelli, A., Presta, M., Rusnati, M., Ziche, M., Rubartelli, A., Paglialunga, G., Bussolino, A., & Noonan, D. (1996). HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene, 12(2), 289-297.
-
- Aleem, A. R., Shahzadi, L., Alvi, F., Khan, A. F., Chaudhry, A. A., Rehman, U. I., & Yar, M. (2017). Thyroxin releasing chitosan/collagen based smart hydrogels to stimulate neovascularization. Materials & Design, 133, 416-425.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical